Income Statement Evolution. Please enable JavaScript in your browser's settings to use dynamic charts. EPS Revisions. More Estimates Revisions. Managers and Directors. More about the company.
Sector and Competitors. More Results. All rights reserved. Show password. Add to my list Report. Most relevant. All News. Analyst Reco. Other languages.
Press Releases. Official Publications. Sector news. You can enter multiple email addresses separated by commas. More news. More recommendations. Financials USD Sales In addition, the forward-looking statements included in this press release represent our views as of December 6, We anticipate that subsequent events and developments will cause our views to change.
However, while we may elect to update these forward-looking statements at some point in the future, we specifically disclaim any obligation to do so. Investor Contact: Acurx Pharmaceuticals, Inc. David P. Search markets. News The word News. My Watchlist My Watchlist. Benzinga 45d. MarketWatch 46d. Seeking Alpha 60d. PR Newswire 62d. PR Newswire 67d. Developing a medicine takes many years. Find out about our clinical trials process, how we work with doctors and volunteers throughout this process, and how to become a research volunteer.
You are currently visiting our global website. This information was updated on 27 October All have due dates of 21 Jan Optimizing dosing strategies for obese patients and in continuous. Updated global antibacterial pipeline review from Pew Trusts. March 10, John Rex. The big conclusion will not be a surprise to this audience! Go here for details. Go here for current details. CARB-X recently announced that their existing resources will be reserved to fund their existing portfolio more than 80 total awards, and counting, as they include contracting from prior rounds.
Read more about it here. Sign-up for here to learn more. Go here to for more details. Go here to register. Go here for more details and registration.
0コメント